http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104130971-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f75adabd8527485d294009c3d1595f |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 |
| filingDate | 2014-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d24d36417c92644557b941403e3ac43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76419147d6cbb277105abfd5a7fbb284 |
| publicationDate | 2015-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104130971-B |
| titleOfInvention | Serum-free medium of recombinant human erythropoietin, applications of serum-free medium and method for preparing recombinant human erythropoietin |
| abstract | The invention relates to the field of biological pharmacy, and in particular relates to a serum-free medium of recombinant human erythropoietin, applications of the serum-free medium and a method for preparing the recombinant human erythropoietin. The medium comprises a basal medium and additives; wherein the additives comprise 4-(2-hydroxyerhyl) piperazine-1-erhaesulfonic acid, NaHCO3, soy protein hydrolysate, sodium butyrate, D-glucose, D-mannose, D-galactose and N-acetyl glucosamine. The medium disclosed by the invention has the advantages that the expression quantity of CHO cells in the serum-free culture stage is increased; the proportion of expression of high-activity EPO by the CHO cells in the serum-free culture stage is increased; the survival time of the cells in the serum-free state is prolonged; the yield of EPO is increased. |
| priorityDate | 2014-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 74.